Table 6 The results for each histological subtype when applying the model to the external validation set.

From: A prediction model using 2-propanol and 2-butanone in urine distinguishes breast cancer

BCP

HC

Subtype

True Positive

False Negative

Sensitivity (%)

True Negative

False Positive

Specificity (%)

Luminal A-like

22

5

81.5

105

11

90.5

Luminal B-like

8

1

88.9

Luminal HER2-like

3

1

75.0

Pure HER2-like

2

1

66.7

Triple-negative-like

7

0

100.0

  1. BCP breast cancer patient, HC healthy control.
Back to article page